Signature Estate & Investment Advisors’s Medtronic MDT Stock Holding History

Signature Estate & Investment Advisors’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$209K	Sell	2,668 -131	-5%	-$10.6K	﹤0.01%	640
2026 Q1	$243K	Buy	2,799 +208	+8%	+$19.9K	﹤0.01%	583
2025 Q4	$249K	Sell	2,591 -289	-10%	-$28.1K	0.01%	542
2025 Q3	$274K	Sell	2,880 -685	-19%	-$63K	0.01%	512
2025 Q2	$311K	Sell	3,565 -516	-13%	-$43.8K	0.01%	455
2025 Q1	$367K	Buy	4,081 +410	+11%	+$36.7K	0.01%	399
2024 Q4	$293K	Sell	3,671 -518	-12%	-$44.8K	0.01%	427
2024 Q3	$377K	Sell	4,189 -90	-2%	-$7.57K	0.01%	369
2024 Q2	$337K	Buy	+4,279	New	+$351K	0.01%	366

Other funds holding MDT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

First Eagle Investment Management New York $59.9B AUM 27.01% 1-Year Est. Return

SG Americas Securities New York $179B AUM 65.34% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

MGP

M&G plc London, United Kingdom $20.1B AUM 16.62% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Signature Estate & Investment Advisors's MDT Position: Q2 2026 in Review

Signature Estate & Investment Advisors reduced its Medtronic (MDT) stake by 4.7% in Q2 2026, selling an estimated $10.6K and leaving 2,668 shares worth $209K. The position accounts for ﹤0.01% of the portfolio, ranked #640.

Signature Estate & Investment Advisors first reported a position in MDT in Q2 2024 and has held it in 9 quarters since. The position peaked at $377K in Q3 2024. 1,329 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

Signature Estate & Investment Advisors held 2,668 shares of Medtronic worth $209K as of Q2 2026.
Signature Estate & Investment Advisors sold 131 Medtronic shares in Q2 2026, an estimated $10.6K.
Medtronic made up ﹤0.01% of Signature Estate & Investment Advisors's portfolio in Q2 2026, its #640 holding.
Signature Estate & Investment Advisors first reported a position in Medtronic in Q2 2024 and has held it in 9 quarters since.
Signature Estate & Investment Advisors's Medtronic position peaked at $377K in Q3 2024.
1,329 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Signature Estate & Investment Advisors's 13F filing for Q2 2026, filed 14 Jul 2026.